Abstract:Background Ceramide is a bioeffector that mediates various cellular processes, including apoptosis. However, the mechanism underlying ceramide function in apoptosis is apparently cell type-dependent and is not well-understood. We aimed at identifying molecular targets of ceramide in metastatic human colon and breast cancer cells, and determining the efficacy of ceramide analog in suppression of colon and breast cancer metastasis. Methods The activity of and mechanism underlying ceramide as a cytotoxic agent, and as a sensitizer for Fas-mediated apoptosis was analyzed in human cell lines established from primary or metastatic colon and breast cancers. The efficacy of ceramide analog LCL85 in suppression of metastasis was examined in preclinical mouse tumor models. Results Exposure of human colon carcinoma cells to ceramide analog LCL85 results in apoptosis in a dose-dependent manner. Interestingly, a sublethal dose of LCL85 increased C16 ceramide content and overcame tumor cell resistance to Fas-mediated apoptosis. Subsequently, treatment of tumor cells with exogenous C16 ceramide resulted in increased tumor cell sensitivity to Fas-mediated apoptosis. LCL85 resembles Smac mimetic BV6 in sensitization of colon carcinoma cells to Fas-mediated apoptosis by inducing proteasomal degradation of cIAP1 and xIAP proteins. LCL85 also decreased xIAP1 and cIAP1 protein levels and sensitized metastatic human breast cancer cells to Fas-mediated apoptosis. Silencing xIAP and cIAP1 with specific siRNAs significantly increased the metastatic human colon carcinoma cell sensitivity to Fas-mediated apoptosis, suggesting that IAP proteins mediate apoptosis resistance in metastatic human colon carcinoma cells and ceramide induces IAP protein degradation to sensitize the tumor cells to apoptosis induction. Consistent with its apoptosis sensitization activity, subtoxic doses of LCL85 suppressed colon carcinoma cell metastatic potential in an experimental lung metastasis mouse model, as well as breast cancer growth and spontaneous lung metastasis in an orthotopic breast cancer mouse model. Conclusion We have identified xIAP and cIAP1 as molecular targets of ceramide and determined that ceramide analog LCL85 is an effective sensitizer in overcoming resistance of human cell lines established from metastatic colon and breast cancers to apoptosis induction to suppress metastasis in vivo .

Ceramide Induces Cell Cycle Arrest and Upregulates P27kip in Nasopharyngeal Carcinoma Cells.

Induction of apoptosis by ceramide in nasopharyngeal carcinoma cell line CNE 2

Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma.

C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cells.

Apoptosis Induced by Ceramide in Hepatocellular Carcinoma Bel7402 Cells.

Induction of Apoptosis by Ceramide in Human Breast Carcinoma Cells

Induction of ER Stress-Mediated Apoptosis by Ceramide Via Disruption of ER Ca2+ Homeostasis in Human Adenoid Cystic Carcinoma Cells

Inhibitory effect of histone H3K27 methylation on proliferation of human well-differentiated nasopharyngeal carcinoma cell line CNE-1

Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells

Ceramide induces the apoptosis of non‐small cell lung cancer cells through the Txnip/Trx1 complex

C24‐Ceramide Drives Gallbladder Cancer Progression Through Directly Targeting Phosphatidylinositol 5‐Phosphate 4‐Kinase Type‐2 Gamma to Facilitate Mammalian Target of Rapamycin Signaling Activation

EGFR Tyrosine Kinase Inhibitor AG1478 Inhibits Cell Proliferation and Arrests Cell Cycle in Nasopharyngeal Carcinoma Cells

Mechanism of 5-Aza-2′-deoxycytidine Inhibiting the Growth of CNE Cell Line

2-Methoxyestradiol Induces Cell Cycle Arrest and Apoptosis of Nasopharyngeal Carcinoma Cells

Influence of 5 - Aza - 2' - Deoxycytidine on the Proliferation, Apoptosis and Cycle of Nasopharyngeal Carcinoma Cell Lines

Ceramide Targets Xiap and Ciap1 to Sensitize Metastatic Colon and Breast Cancer Cells to Apoptosis Induction to Suppress Tumor Progression

Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

C6-ceramide Induces Salivary Adenoid Cystic Carcinoma Cell Apoptosis Via IP3R-activated UPR and UPR-independent Pathways.

The IRF2/CENP-N/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis

Potential effect of MSR1 and C6 ceramide small molecules on nasopharyngeal carcinoma based on GSEA analysis

[Inhibition of cell growth by rapamycin through targeting mammalian target of rapamycin signaling pathway in nasopharyngeal carcinoma].